Why the study?
Do secondary cardiac prevention programs reduce mortality and recurrent myocardial infarction in patients with coronary disease?
Population
21,295 patients with coronary disease from 63 randomized trials
Comparison
Secondary cardiac prevention programs vs Control group
Design
Meta-analysis
Follow-up
median 12 months (up to 24 months)
Authors
Loading...
Secondary prevention programs merit routine post-coronary disease use; reinforces mortality and MI benefits across program types.
Do secondary cardiac prevention programs reduce mortality and recurrent myocardial infarction in patients with coronary disease?
A wide variety of secondary prevention programs, regardless of whether they include an exercise component, significantly reduce all-cause mortality and recurrent myocardial infarction in patients with coronary disease.
Clark et al. (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: